Who should use our products?

Launched at the 44th ASCO Annual Meeting held in May 2008 in Chicago, IL, USA, MapQuant Dx™ Genomic Grade test and the MapQuant Dx™ Testing Solution are commercially available for European healthcare centers.

Prescribers are physicians specialized in tissue analysis (pathologists) and in cancer care (oncologists).